Centre Hospitalier Universitaire de Rennes
Centre Hospitalier Universitaire de Rennes
Rennes, France8 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ATTUNE Revision System in the Revision Total Knee Arthroplasty Population | Revision Total Knee Arthroplasty | Active, not recruiting | Not applicable | 2026-09-28 | NCT03153475 | |
| ATTUNE® Revision- Complex Primary in Total Knee Arthroplasty Population | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Joint Instability, arthropathy, musculoskeletal system disorder | Active, not recruiting | Not applicable | 2026-09-25 | NCT03153449 | |
| Acetylsalicylic Acid Versus Placebo as an add-on Treatment to Local Non-steroidal Anti-inflammatory Drug for the Management of Thrombotic Episodes in Superficial Venous Malformations in Children Aged 6 to 17 Years. | Venous Malformation, Low Flow; Venous Malformations | Not yet recruiting | Phase 2 | 2026-06-23 | NCT07663825 | |
| ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES | Aneurysm, abdominal aortic aneurysm, aortic aneurysm, aortic disorder, cardiovascular disorder, vascular disorder | Recruiting | Not applicable | 2026-05-22 | NCT04503395 | |
| Efficacy of Intravesical Oxybutynin in Children With Neurogenic Bladder Dysfunction | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, central nervous system malformation, nervous system disorder, spina bifida | Recruiting | Phase 3 | 2026-04-14 | NCT07027020 | |
| Study to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid Tumours | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung cancer, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 1 | 2026-04-03 | NCT05752552 | |
| A Study to Assess the Safety and Effectiveness of the UrOActive® Artificial Urinary sPHincter (AUS) | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, Male Urogenital Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urinary Incontinence, Urinary Incontinence, Stress, Urination Disorders, Urogenital Diseases, Urological Manifestations, urinary system disorder | Recruiting | Not applicable | 2026-03-27 | NCT06968741 | |
| First-line EXL01 With Nivolumab and FOLFOX for PD-L1 CPS ≥5 Metastatic Gastric Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric cancer, gastric neoplasm, neoplasm, stomach disorder | Recruiting | Phase 2 | 2025-09-22 | NCT06253611 |